Expression of CD44 in Canine Mammary Tumours

Journal of Comparative Pathology

Volumn 141, Issue 4, 2009, Pages 237-247

  Paltian, V ^a   Alldinger, S ^a   Baumgartner W ^a   Wohlsein, P ^a  

^a UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

CD44; dog; immunohistochemistry; mammary tumour

Indexed keywords

HERMES ANTIGEN;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BLOOD VESSEL; BREAST ADENOMA; BREAST CARCINOMA; BREAST DUCT; BREAST EPITHELIUM; BREAST HYPERPLASIA; BREAST TUMOR; CONTROLLED STUDY; DISEASE ACTIVITY; DOG DISEASE; EPITHELIUM CELL; HISTOPATHOLOGY; MYOEPITHELIUM CELL; NONHUMAN; PRIORITY JOURNAL; STROMA CELL; UPREGULATION;

ADENOMA; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD44; CARCINOMA; DOG DISEASES; DOGS; FEMALE; IMMUNOHISTOCHEMISTRY; MAMMARY GLANDS, ANIMAL; MAMMARY NEOPLASMS, ANIMAL; NEOPLASM STAGING; STATISTICS, NONPARAMETRIC;

CANIS FAMILIARIS;

EID: 71549168915     PISSN: 00219975     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcpa.2009.05.007     Document Type: Article

References (48)

1. Alldinger S., Baumgärtner W., Kremmer E., and Fonfara S. Characterization of a canine CD44 specific monoclonal antibody. Journal of Veterinary Medicine A 46 (1999) 19-32
2. Alldinger S., Fonfara S., Kremmer E., and Baumgärtner W. Up-regulation of the hyaluronate receptor CD44 in canine distemper demyelinated plaques. Acta Neuropathologica 99 (2000) 138-146
3. Auvinen P., Tammi R., Tammi M., Johansson R., and Kosma V.-M. Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan. Histopathology 47 (2005) 420-428
4. Bankfalvi A., Terpe H.-J., Breukelmann D., Bier B., Rempe D., et al. Gains and losses of CD44 expression during breast carcinogenesis and tumour progression. Histopathology 33 (1998) 107-116
5. Berner H.S., Suo Z., Risberg B., Villman K., Karlsson M.G., et al. Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas. Histopathology 42 (2003) 546-554
6. Bland J.M., and Altman D.G. Multiple significance tests: the Bonferroni method. British Medical Journal 310 (1995) 170
7. Borland G., Ross J.A., and Guy K. Forms and functions of CD44. Immunology 93 (1998) 139-148
8. Bostock D.E. Canine and feline mammary neoplasms. British Veterinary Journal 142 (1986) 506-515
9. Bourguignon L.Y.W. CD44-mediated oncogenic signaling and cytoskeleton activation during mammary tumour progression. Journal of Mammary Gland Biology and Neoplasia 6 (2001) 287-297
10. Bourguignon L.Y.W., Iida N., Welsh C.F., Zhu D., Krongrad A., et al. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. Journal of Neuro-oncology 26 (1995) 201-208
11. Brodey R.S., Goldschmidt M.H., and Roszel J.R. Canine mammary gland neoplasms. Journal of the American Animal Hospital Association 19 (1983) 61-90
12. Charpin C., Garcia S., Bouvier C., Devictor B., Andrac L., et al. Automated and quantitative immunocytochemical assays of CD44v6 in breast carcinomas. Human Pathology 28 (1997) 289-296
13. Culty M., Shizari M., Thompson E.W., and Underhill C.B. Binding and degradation of hyaluronan by human breast cancer cell lines expressing different forms of CD44: correlation with invasive potential. Journal of Cell Physiology 160 (1994) 275-286
14. Dall P., Heider K.-H., Sinn H.-P., Skroch-Angel P., Adolf G., et al. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer. International Journal of Cancer 60 (1995) 471-477
15. Foekens J., Dall P., Klijn J.G.M., Skroch-Angel P., Claassen C.J.C., et al. Prognostic value of CD44 variant expression in primary breast cancer. International Journal of Cancer 84 (1999) 209-215
16. Fox S.B., Fawcett J., Jackson D.G., Collins I., Gatter K.C., et al. Normal human tissues, in addition to some tumours, express multiple different CD44 isoforms. Cancer Research 54 (1994) 4539-4546
17. Friedrichs K., Franke F., Lisboa B.-W., Kügler G., Gille I., et al. CD44 isoforms correlate with cellular differentiation but not with prognosis in human breast cancer. Cancer Research 55 (1995) 5424-5433
18. Goldstein L.A., Zhou D.F.H., Picker L.J., Minty C.N., Bargatze R.F., et al. A human lymphocyte homing receptor, the Hermes antigen, is related to cartilage proteoglycan core and link proteins. Cell 56 (1989) 1063-1072
19. Goodison S., and Tarin D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopathology 32 (1998) 1-6
20. 0 breast carcinomas. Breast Cancer Research and Treatment 44 (1997) 261-268
21. Hebbard L., Steffen A., Zawadzki V., Fieber C., Howells N., et al. CD44 expression and regulation during mammary gland development and function. Journal of Cell Science 113 (2000) 2619-2630
22. Heider K.-H., Dämmrich J., Skroch-Angel P., Müller-Hermelink H.-K., Vollmers H.P., et al. Differential expression of CD44 splice variants in intestinal- and diffuse-type human gastric carcinomas and normal gastric mucosa. Cancer Research 53 (1993) 4197-4203
23. Herrlich P., Morrison H., Sleeman J., Orian-Rousseau V., König H., et al. CD44 acts both as a growth- and invasiveness-promoting molecule and as a tumor-suppressing cofactor. Annals of the New York Academy of Sciences 910 (2000) 106-120
24. Jansen R.H.L., Joosten-Achjanie S.R., Arends J.W., Volovics A., Hupperets P.S.G.J., et al. CD44v6 is not a prognostic factor in primary breast cancer. Annals of Oncology 9 (1998) 109-111
25. Kaufmann M., Heider K.-H., Sinn H.-P., von Minckwitz G., and Ponta H. CD44 variant exon epitopes in primary breast cancer and length of survival. Lancet 345 (1995) 615-619
26. Lesley J., Hyman R., English N., Catterall J.B., and Turner G.A. CD44 in inflammation and metastasis. Glycoconjugate Journal 14 (1997) 611-621
27. Laurent T.C., and Fraser J.R.E. Hyaluronan. FASEB Journal 6 (1992) 2397-2404
28. Lopez J.I., Camenisch T.D., Stevens M.V., Sands B.J., McDonald J., et al. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Research 65 (2005) 6755-6763
29. Mackay C.R., Terpe H.-J., Stauder R., Marston W.L., Stark H., et al. Expression and modulation of CD44 variant isoforms in humans. Journal of Cell Biology 124 (1994) 71-82
30. Misdorp W., Else R.W., Hellmen E., and Lipscomp T.P. Histological classification of mammary tumors of the dog and the cat. WHO International Histological Classification of Tumors of Domestic Animals, 2nd series, Vol. VII (1999), Armed Forces Institute of Pathology, American Registry of Pathology, Washington, DC
31. Moore P.F., Schrenzel M.D., Affolter V.K., Olivry T., and Naydan D. Canine cutaneous histiocytoma is an epidermotropic Langerhans cell histiocytosis that expresses CD1 and specific β2-integrin molecules. American Journal of Pathology 148 (1996) 1699-1708
32. Morris S.F., O'Hanlon D.M., McLughlin R., McHale T., Connolly G.E., et al. The prognostic significance of CD44s and CD44v6 expression in stage two breast carcinoma: an immunohistochemical study. European Journal of Surgical Oncology 27 (2001) 527-531
33. Mundform D.J., Perrett J.J., Schaffer J., Piccone A., and Roozeboom M. Bonferroni adjustments in tests for regression coefficients. Multiple Linear Regression Viewpoints 32 (2006) 1-6
34. Nolte I., Nolte M., and von Bomhard D. Praxis der Onkologie bei Hund und Katze - Epidemiologie (2001), Enke Press, Stuttgart
35. Ponta H., Wainwright D., and Herrlich P. The CD44 protein family. International Journal of Biochemistry and Cell Biology 30 (1998) 299-305
36. Regidor P.A., Callies R., Regidor M., Gunthert U., Zoller M., et al. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters. Archives of Gynecology and Obstetrics 258 (1996) 125-135
37. Screaton G.R., Bell M.V., Jackson D.G., Cornelis F.B., Gerth U., et al. Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons. Proceedings of the National Academy of Sciences USA 89 (1992) 12160-12164
38. Schumacher U., Horny H.P., Horst H.A., Herrlich P., and Kaiserling E. A CD44 variant exon 6 epitope as a prognostic indicator in breast cancer. European Journal of Surgical Oncology 22 (1996) 259-261
39. Serra M., Rabanal R.M., Miquel L., Domenzain C., and Bassols A. Differential expression of CD44 in canine melanocytic tumours. Journal of Comparative Pathology 130 (2004) 171-180
40. Sinicrope F.A., Ruan S.B., Cleary K.R., Stephens L.C., Lee J.J., et al. Bcl-2 and p53 oncoprotein during colorectal tumourigenesis. Cancer Research 55 (1995) 237-241
41. Sinn H.P., Heider K.H., Skroch-Angel P., von Minckwitz G., Kaufmann M., et al. Human mammary carcinomas express homologues of rat metastasis-associated variants of CD44. Breast Cancer Research and Treatment 36 (1995) 307-313
42. Sugino T., Gorham H., Yoshida K., Bolodeoku J., Nargund V., et al. Progressive loss of CD44 gene expression in invasive bladder cancer. American Journal of Pathology 149 (1996) 873-882
43. Tempfer C., Lösch A., Heinzl H., Häusler G., Hanzal E., et al. Prognostic value of immunohistochemically detected CD44 isoforms CD44v5, CD44v6 and CD44v7-8 in human breast cancer. European Journal of Cancer 32A (1996) 2023-2025
44. Terpe H.J., Stark H., Prehm P., and Günthert U. CD44 variant isoforms are preferentially expressed in basal epithelia of non-malignant human fetal and adult tissues. Histochemistry 101 (1994) 79-89
45. Turley E.A., Noble P.W., and Bourguignon L.Y. Signaling properties of hyaluronan receptors. Journal of Biological Chemistry 7 (2002) 4589-4592
46. Van Hal N.L.W., van Dongen G.A.M.S., Stigter-van Walsum M., Snow G.B., and Brakenhoff R.H. Characterization of CD44v6 isoforms in head-and-neck squamous cell carcinoma. International Journal of Cancer 82 (1999) 837-845
47. Wellman M.L., Krakowka S., Jacobs R.M., and Kociba G.J. A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cellular Development and Biology 24 (1988) 223-229
48. Wünschmann A., Kremmer A., and Baumgärtner W. Phenotypical characterization of T and B cells areas in lymphoid tissues of dogs with spontaneous distemper. Veterinary Immunology and Immunopathology 73 (2000) 83-98